Update on Psoriasis Comorbidities: Report From the AAD Meeting

At the 73rd Annual Meeting of the American Academy of Dermatology in San Francisco, California, Dr. Jashin J. Wu reviews data on the risk for cardiovascular and noncardiovascular comorbidities in psoriasis patients. He discusses patients with hypertension and how psoriasis disease severity impacts control of hypertension. Noncardiovascular comorbidities such as chronic obstructive pulmonary disease, gallstones, end-stage kidney disease, and others, are evaluated.

At the 73rd Annual Meeting of the American Academy of Dermatology in San Francisco, California, Dr. Jashin J. Wu reviews data on the risk for cardiovascular and noncardiovascular comorbidities in psoriasis patients. He discusses patients with hypertension and how psoriasis disease severity impacts control of hypertension. Noncardiovascular comorbidities such as chronic obstructive pulmonary disease, gallstones, end-stage kidney disease, and others, are evaluated.

At the 73rd Annual Meeting of the American Academy of Dermatology in San Francisco, California, Dr. Jashin J. Wu reviews data on the risk for cardiovascular and noncardiovascular comorbidities in psoriasis patients. He discusses patients with hypertension and how psoriasis disease severity impacts control of hypertension. Noncardiovascular comorbidities such as chronic obstructive pulmonary disease, gallstones, end-stage kidney disease, and others, are evaluated.